The market performance of Royalty Pharma plc has been somewhat stable. Over the past year, the company’s stock achieved a high of $34.20 on 02/24/25, with the lowest value for the same timeframe being $24.05, recorded on 12/19/24.
52-week price history of RPRX Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Royalty Pharma plc’s current trading price is -8.86% away from its 52-week high, while its distance from the 52-week low is 29.60%. The stock’s price range during this period has fluctuated between $24.05 and $34.20. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 4.7 million for the day, which was evidently higher than the average daily volume of 4.51 million over the last three months.
Financial Performance and Market Capitalization
Royalty Pharma plc (RPRX) has experienced a quarterly rise of 22.04% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 17.97B and boasts a workforce of 99 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 29.40, with a change in price of +3.97. Similarly, Royalty Pharma plc recorded 4,050,656 in trading volume during the last 100 days, posting a change of +14.60%.
RPRX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RPRX stands at 1.10. Similarly, the long-term debt-to-equity ratio is also 0.95.
RPRX Stock Stochastic Average
The raw stochastic average for Royalty Pharma plc over the last 50 days is presently at 32.29%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 15.14%. Further, the company’s Stochastic %K and %D values for the last 20 days were 13.64% and 12.59%, respectively.
RPRX Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant gain of 22.19% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 10.49%. Over the past 30 days, the price of RPRX has leaped by -7.94%. And in the last five days, it has fallen by -7.67%.
